Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-17
2007-04-17
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S336000, C544S408000, C544S180000, C544S216000, C544S297000, C544S298000, C514S241000, C514S245000, C514S269000, C514S272000, C514S345000, C514S352000, C546S300000, C546S301000
Reexamination Certificate
active
10476196
ABSTRACT:
The present invention provides a compound which is useful as a PGI2receptor agonist, and a pharmaceutical composition.The present invention is directed to a pharmaceutical composition comprising a compound represented by the following formula [1]:(R1and R2are the same or different and each represents optionally substituted aryl, Y represents N or CH, Z represents N or CH, A represents NH, NR5, O, S, or ethylene, R5represents alkyl, D represents alkylene or alkenylene, E represents phenylene or single bond, G represents O, S, or CH2, R3and R4are the same or different and each represents hydrogen or alkyl, Q represents carboxy, alkoxycarbonyl, tetrazolyl, carbamoyl, or N-(alkylsulfonyl)carbamoyl), or a pharmaceutically acceptable salt thereof as an active ingredient.
REFERENCES:
patent: 0 088 593 (1983-09-01), None
patent: 1 604 084 (1981-12-01), None
patent: 7-33752 (1992-02-01), None
patent: 5-208961 (1993-08-01), None
patent: 5-508845 (1993-12-01), None
patent: WO-92/01675 (1992-02-01), None
patent: WO-92/02513 (1992-02-01), None
Meanwell, Nicholas A. et al., Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moiety, J. Med. Chem., 1992, vol. 35, No. 19, pp. 3498 to 3512; particularly, compound Nos. 13aw, 13ax, 13aaa on table II.
Konno, Shoetsu et al., Studies on as-triazine derivatives. XIX. Synthesis of 2, 3-diarylpyrazine and 2, 3-diarypyridine derivatives as blood platelet aggregation inhibitors. Yakugaku Zasshi, 1993, vol. 113, No. 1, pp. 40 to 52; particularly, tables III, IV.
Bhalla, M. et al., Synthesis and pharmacological evaluation of 1, 2, 4-triazine and its congeners, Boll. Chim. Farm., 1995, vol. 134, No. 1, pp. 9 to 15; compounds on formulas IV, V of Fig. 1.
Asaki Tetsuo
Hamamoto Taisuke
Kuwano Keiichi
Balasubramanian Venkataraman
Darby & Darby
Nippon Shinyaku Co. Ltd.
LandOfFree
Heterocyclic compound derivatives and medicines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compound derivatives and medicines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compound derivatives and medicines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3796740